GENSIA Trademark

Trademark Overview

On Wednesday, August 17, 2022, a trademark application was filed for GENSIA with the United States Patent and Trademark Office. The USPTO has given the GENSIA trademark a serial number of 97553238. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, October 7, 2023. This trademark is owned by Gensia Biologics, Inc. The GENSIA trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of Cancer, Anemia, Rheumatoid arthritis (RA), Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, Diabetes, Multiple sclerosis (MS), Heart attack, Systemic lupus erythematous, Age-related macular degeneration, Diabetes, Diabetic retinopathy, Prevention of pneumonia, Anemia, Chronic migraine, Hepatitis B, Hemophilia, Respiratory syncytial virus (RSV) prophylaxis, HPV prevention, Varicella virus vaccine, Growth hormone deficiency, Botox, Osteoporosis, Allergic asthma, Chronic idiopathic urticaria, Infertility, Prevention of meningococcal disease, Cystic fibrosis, Paroxysmal nocturnal hemoglobinuria, and recombinant biological agents
gensia

General Information

Serial Number97553238
Word MarkGENSIA
Filing DateWednesday, August 17, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, October 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological preparations for the treatment of Cancer, Anemia, Rheumatoid arthritis (RA), Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Psoriasis, Diabetes, Multiple sclerosis (MS), Heart attack, Systemic lupus erythematous, Age-related macular degeneration, Diabetes, Diabetic retinopathy, Prevention of pneumonia, Anemia, Chronic migraine, Hepatitis B, Hemophilia, Respiratory syncytial virus (RSV) prophylaxis, HPV prevention, Varicella virus vaccine, Growth hormone deficiency, Botox, Osteoporosis, Allergic asthma, Chronic idiopathic urticaria, Infertility, Prevention of meningococcal disease, Cystic fibrosis, Paroxysmal nocturnal hemoglobinuria, and recombinant biological agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGensia Biologics, Inc
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, October 7, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, October 7, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NON-FINAL ACTION WRITTEN
Sunday, June 4, 2023ASSIGNED TO EXAMINER
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 20, 2022NEW APPLICATION ENTERED

Related Keywords

gensia prevention disease virus diabetes anemia biological chronic hormone growth botox